NASDAQ · Financial Statements
Tenaya Therapeutics, Inc. (TNYA) Financial Statements
$0.58
NASDAQ: TNYA
Market Cap $126.51M
Overview Financials Dividend Tenaya Therapeutics, Inc. most recently reported annual revenue of $0, net profit of $-91.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
Annual Financials (USD)
Metric 2021 2022 2023 2024 2025 Revenue $0 $0 $0 $0 $0 Operating Profit $-73.0M $-126.0M $-131.0M $-116.0M $-93.0M Net Profit $-73.0M $-124.0M $-124.0M $-111.0M $-91.0M EPS $-1.69 $-2.76 $-1.68 $-1.31 $-0.59 Op Margin — — — — —
Balance Sheet (USD)
Metric 2021 2022 2023 2024 2025 Total Assets $317.0M $279.0M $171.0M $120.0M $147.0M Total Liabilities $38.0M $36.0M $31.0M $27.0M $24.0M Cash $38.0M $95.0M $46.0M $4.0M $101.0M Borrowings $16.0M $15.0M $12.0M $14.0M $11.0M
Cash Flow (USD)
Metric 2021 2022 2023 2024 2025 Operating Cash Flow $-61.0M $-104.0M $-102.0M $-91.0M $-68.0M Investing Cash Flow $-264.0M $63.0M $47.0M $0 $55.0M Financing Cash Flow $0 $0 $0 $1.0M $0 Net Cash Flow $-90.0M $57.0M $-49.0M $-42.0M $96.0M Free Cash Flow $-86.0M $-125.0M $-103.0M $-92.0M $-69.0M
Valuation & Return Ratios
Metric Value PEG Ratio -0.02 EV / EBITDA -0.50 FCF Yield -58.68% Quick Ratio 4.52 Interest Coverage 0.00 Return 1Y 21.66% Return 3Y -84.24% Return 5Y —
Screens featuring this stock